198 results on '"van der Kwast, T.H."'
Search Results
2. Proportion of Gleason 8-10 prostate cancer found on biopsy and tumor aggressiveness in matched cohorts of men in Asia and Western countries
3. The importance of being grade 3 in primary non-muscle invasive bladder cancer
4. Tumor heterogeneity of fibroblast growth factor receptor 3 (FGFR3) mutations in invasive bladder cancer: implications for perioperative anti-FGFR3 treatment
5. Development, multi-institutional external validation, and algorithmic audit of SEPERA – An artificial intelligence-based side-specific extra-prostatic extension risk assessment tool for patients undergoing radical prostatectomy
6. Prognosis of primary papillary Ta-G3 bladder cancer in the non-muscle invasive spectrum
7. Should Follow-up Biopsies for Men on Active Surveillance for Prostate Cancer Be Restricted to Limited Templates?
8. O3 - Prognosis of primary papillary Ta-G3 bladder cancer in the non-muscle invasive spectrum
9. Salvage Radical Prostatectomy Following Primary High Intensity Focused Ultrasound for Treatment of Prostate Cancer
10. Prostate cancer: Trends in incidence, survival and mortality in the Netherlands, 1989–2006
11. A1035 - The importance of being grade 3 in primary non-muscle invasive bladder cancer
12. A0362 - Evaluation of the long term recurrence risk, metastatic potential and length of cystoscopic surveillance of low-grade non-muscle invasive bladder cancer
13. P045 - Proportion of Gleason 8-10 prostate cancer found on biopsy and tumor aggressiveness in matched cohorts of men in Asia and Western countries
14. Cribriform and intraductal carcinoma do not improve the nomogram-based selection of prostate cancer patients for pelvic lymph node dissection
15. Prostate cancer localization with multispectral MRI using cost-sensitive support vector machines and conditional random fields
16. My approach to intraductal lesions of the prostate gland
17. Prediction of Indolent Prostate Cancer: Validation and Updating of a Prognostic Nomogram
18. The genomic landscape of unsuspected, incidentally detected Gleason 7 prostate cancer found on autopsy
19. Tumor characteristics and prognostic factors in two subsequent screening rounds with four-year interval within prostate cancer screening trial, ERSPC Rotterdam
20. P119 - Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, non-invasive bladder tumors in 2019?
21. Differences in contemporary biopsy Gleason score distribution in large cohorts of men diagnosed with prostate cancer from China and Canada
22. Current treatment options for locally advanced prostate cancer: EAU (-SIOG) guidelines view and recommendations
23. 4 - Development, multi-institutional external validation, and algorithmic audit of SEPERA – An artificial intelligence-based side-specific extra-prostatic extension risk assessment tool for patients undergoing radical prostatectomy
24. Virus Specific Immune Responses after Human Neoadjuvant Adenovirus-mediated Suicide Gene Therapy for Prostate Cancer
25. Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men
26. 31 Cribriform groeipatroon in prostaatkanker met Gleason-score 7 is voorspellend voor metastase- en ziektespecifieke overleving
27. Interval carcinomas in the European randomized study of screening for prostate cancer (ERSPC)-Rotterdam
28. Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure
29. Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, non-invasive bladder tumors in 2019?
30. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study)
31. Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies.
32. Germline variation at 8q24 and prostate cancer risk in men of European ancestry.
33. Erratum to: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (Nature Communications, (2018), 9, 1, (4616), 10.1038/s41467-018-06863-1).
34. P031 - Cribriform and intraductal carcinoma do not improve the nomogram-based selection of prostate cancer patients for pelvic lymph node dissection
35. P1019 - The genomic landscape of unsuspected, incidentally detected Gleason 7 prostate cancer found on autopsy
36. FGFR3 mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?
37. Molecular markers (FGFR3 mutation; p53 and Ki-67 expression) and clinical outcome of radical cystectomy for bladder cancer: A multi-center, multi-laboratory study
38. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants.
39. What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis
40. Should centralized histopathological review in prostate cancer be the gold standard?
41. 1074 - FGFR3 mutations and their relation to FGFR3 expression and clinical outcome in a large radical cystectomy cohort: Implications for anti-FGFR3 bladder cancer treatment?
42. Molecular tumour grading and classification of non muscle invasive bladder cancer based on whole transcriptome analysis
43. Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma
44. PT008 - What is the negative predictive value of multiparametric magnetic resonance imaging in excluding prostate cancer at biopsy? A systematic review and meta-analysis
45. 611 Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy
46. 115 Gleason score reclassification of men with classical Gleason score ≤6 who eventually died of prostate cancer in the ERSPC Rotterdam
47. 423 Functional role of the kallikrein 6 region of the kallikrein locus in genetic predisposition for aggressive (Gleason ≥8) prostate cancer: Fine-mapping and methylation study in a Canadian cohort and the Swiss arm of the European Randomized Study for Prostate Cancer Screening
48. 755 A five-gene DNA-methylation biomarker panel sensitively detects bladder cancer and discriminates between high-grade and low-grade disease in voided urine
49. 20 Creation of the Toronto Biopsy Avoidance Tools (T-BAT) with clinical parameter-only and adipokine biomarker-augmented versions
50. 128 - Molecular tumour grading and classification of non muscle invasive bladder cancer based on whole transcriptome analysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.